abstract |
The present invention relates to a method for preventing or treating cancer comprising at least one selected from the group consisting of miR-28-5p, miR-323-5p, miR-510-5p, miR-552-3p, miR- To a pharmaceutical composition for therapeutic use. The miR-28-5p, miR-323-5p, miR-510-5p, miR-552-3p, miR-608 or their mimetics of the present invention have the effect of promoting apoptosis and inhibiting cell growth, It has a cancer-specific effect and does not affect normal cells, and has no side effects and can be widely used for effective chemotherapy. |